Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
US7553948B2 · kind B2 · utility
5Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2007 |
| Grant date | Jun 30, 2009 |
| Priority date | — |
| Expiry date | Apr 12, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.